This HTML5 document contains 38 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n14http://linked.opendata.cz/resource/drugbank/drug/DB02543/identifier/chebi/
n10http://linked.opendata.cz/resource/drugbank/drug/DB02543/identifier/kegg-compound/
n11http://linked.opendata.cz/resource/drugbank/drug/DB02543/identifier/pdb/
n6http://bio2rdf.org/drugbank:
n8http://linked.opendata.cz/resource/drugbank/drug/DB02543/identifier/pubchem-compound/
admshttp://www.w3.org/ns/adms#
n9http://linked.opendata.cz/resource/drugbank/drug/DB02543/identifier/pubchem-substance/
n15http://linked.opendata.cz/resource/drugbank/drug/DB02543/identifier/drugbank/
n12http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB02543
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB02543 n12:DB02543
dcterms:title
Pyrrole-2-Carboxylate
adms:identifier
n8:3330246 n9:46507534 n10:C05942 n11:PYC n14:36751 n15:DB02543
n3:synthesisReference
Ahmed Abouabdellah, Luc Even, Aude Fayol, Julien Vache, Philippe Yauche, "CYCLOPENTA[C]PYRROLE-2-CARBOXYLATE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF." U.S. Patent US20120095040, issued April 19, 2012.
n3:IUPAC-Name
n4:271B4109-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B410F-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B410E-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B410B-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B410C-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B410D-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4107-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4105-363D-11E5-9242-09173F13E4C5 n4:271B4108-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4106-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4115-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4116-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4110-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4111-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4113-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4112-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4114-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B411B-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B411D-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B411E-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B411A-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4119-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B411C-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B410A-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4117-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4118-363D-11E5-9242-09173F13E4C5